An act relating to administration of involuntary psychiatric medication in emergency circumstances

2025-2026 Regular Session Introduced by Dave Bosch and 8 co-sponsors

The bill sets a framework for emergency involuntary psychiatric medication, outlining when it may be used, how to assess and monitor it, and safeguards to protect patient rights.

Rep. Wood of Waterbury moved that the Committee on Human Services be relieved of the bill and that the same be committed to the Committee on Health Care, which was agreed to

Summary of Bill H 724 (2025-2026) – Vermont

Purpose and intent

H 724 seeks to govern the administration of involuntary psychiatric medication in emergency circumstances.

The bill aims to provide a framework for when and how involuntary medications may be administered to individuals experiencing a psychiatric emergency, balancing clinicians’ ability to prevent harm with protections for the patient’s rights and due process.

Key provisions and changes

The bill delineates conditions under which involuntary psychiatric medication may be administered in emergency settings.

It specifies criteria for determining emergency circumstances, including risk of harm to self or others and the patient’s severe psychiatric decompensation when voluntary treatment is not possible.

Procedures for assessment, documentation, and oversight are included to ensure medical necessity and to minimize coercion.

It sets parameters for the type of medications that may be used, preferred routes of administration, and necessary monitoring for adverse effects.

The bill includes safeguards such as periodic review, reassessment requirements, and potential involvement of patient advocates or legal representatives where applicable.

It may outline timelines for duration of emergency involuntary treatment and criteria for transitioning to voluntary treatment or discharge.

There could be provisions addressing confidentiality, rights of the patient to appeal or request a review, and the role of medical professionals and facility administrators in compliance.

Who would be affected

Patients experiencing acute psychiatric crises who may require emergency involuntary medication.

Mental health care professionals, including psychiatrists, emergency physicians, and hospital staff, who administer or oversee treatment.

Health care facilities (hospitals, emergency departments, and psychiatric units) responsible for implementing emergency involuntary medication procedures.

Legal and patient advocacy entities involved in rights protections, reviews, or appeals related to involuntary treatment.

Family members or designated guardians may be affected insofar as they participate in care planning or advocacy.

Procedural and timeline aspects

The bill indicates initial action in the Vermont General Assembly with a read-first-time and referral to the Committee on Human Services, followed by a committee reallocation motion on January 21, 2026, moving the bill to the Committee on Health Care.

Specific timelines for reviews, approvals, and potential implementation dates are not detailed in the provided summary but would typically be established in committee amendments or a final act.

Oversight and periodic reassessment requirements are likely designed to ensure ongoing compliance and timely patient review, though exact intervals are not specified here.

Practical considerations

The bill directly affects how emergency involuntary psychiatric treatment is administered, potentially reducing the duration of unsafe situations while enforcing patient protections.

Implementation will require clear protocols, staff training, and coordination between medical teams, legal frameworks, and patient rights processes.

Budgetary or resource implications for facilities to meet monitoring, documentation, and review requirements may arise.

If you’d like, I can tailor this summary to emphasize specific stakeholder perspectives (patient rights groups, medical providers, or hospital administrators) or compare it to existing Vermont statutes on involuntary treatment.